Page last updated: 2024-08-25

artemether and Experimental Mammary Neoplasms

artemether has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farsam, V; Hassan, ZM; Mahdavi, M; Noori, S; Ranjbar, M; Zavaran-Hosseini, A	1

Other Studies

1 other study(ies) available for artemether and Experimental Mammary Neoplasms

Article	Year
Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo. International immunopharmacology, 2011, Volume: 11, Issue:11 Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Artemether; Artemisinins; CD4 Antigens; Dose-Response Relationship, Drug; Female; Forkhead Transcription Factors; Hypersensitivity, Delayed; Interleukin-2 Receptor alpha Subunit; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes, Regulatory; Xenograft Model Antitumor Assays	2011

Article

Year

Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.

International immunopharmacology, 2011, Volume: 11, Issue:11

Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Artemether; Artemisinins; CD4 Antigens; Dose-Response Relationship, Drug; Female; Forkhead Transcription Factors; Hypersensitivity, Delayed; Interleukin-2 Receptor alpha Subunit; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes, Regulatory; Xenograft Model Antitumor Assays

2011